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Emodin is one of major compounds in rhubarb (Rheum palmatum L.), a plant used as herbal medicine in Chinese population.
Although many reports have shown that emodin exhibits anticancer activity in many tumor cell types, there is no available
information addressing emodin-aﬀected apoptotic responses in the murine leukemia cell line (WEHI-3) and modulation of the
immune response in leukemia mice. We investigated that emodin induced cytotoxic eﬀects in vitro and aﬀected WEHI-3 cells in
vivo. This study showed that emodin decreased viability and induced DNA fragmentation in WEHI-3 cells. Cells after exposure to
emodinfor24hhaveshownchromatincondensationandDNAdamage.Emodinstimulatedtheproductions ofROS andCa2+ and
reduced thelevel ofΔΨm byﬂowcytometry. Our resultsfrom Westernblottingsuggestthatemodintriggered apoptosisofWEHI-3
cells through the endoplasmic reticulum (ER) stress, caspase cascade-dependent and -independent mitochondrial pathways. In in
vivostudy, emodin enhanced the levels of B cells andmonocytes, and it alsoreduced the weights of liver andspleen compared with
leukemia mice. Emodin promoted phagocytic activity by monocytes and macrophages in comparison to the leukemia mice group.
In conclusions, emodin induced apoptotic death in murine leukemia WEHI-3 cells and enhanced phagocytosis in the leukemia
animalmodel.
1.Introduction
Emodin (1,3,8-trihydroxy-6-methylanthraquinone) isoneof
the major compound in the root of rhubarb (Rheum palma-
tum L.) [1, 2] and possesses immunosuppressive, anticancer,
antiinﬂammatory, antiatherosclerotic, vasorelaxant, and vas-
orelaxant eﬀects [3–5]. Numerous reports have shown that
emodin has antiproliferative eﬀects on many kinds of cancer
cell lines such as HER-2/neu-overexpressing breast cancer
[6, 7], leukemia [8, 9], hepatoma [10], and lung [11]c a n c e r
cells. Also, emodin-triggered apoptosis is mediated through
thecaspase- and mitochondria-dependentpathwaysin prox-
imal tubular epithelial HK-2 cells [12]. Emodin enhanced
geﬁtinib-induced cytotoxicity via Rad51 downregulation
and ERK1/2 inactivation in human breast cancer BCap-37
cells [13]. Therefore, emodin has now been proposed as a
potential agent in the management of tumors [14]. In our
laboratory, we also found that emodin induced apoptosis2 Evidence-Based Complementary and Alternative Medicine
in human tongue squamous cancer SCC-4 cells through
reactive oxygen species (ROS) and mitochondria-dependent
pathways [15], but it has cytotoxic and protective eﬀects in
rat C6 glioma cells, and Mdr1a and nuclear factor kappaB
play important roles in cell survival [16].
L e u k e m i ai so n eo ft h em a j o rc a u s e so fd e a t h si nt h e
human population. In Taiwan, about 4.0 per 100,000 people
die each year of leukemia and it is the 11th most common
malignancybasedonthereportoftheDepartmentofHealth,
Taiwan in 2009 [17]. In the clinical therapy, the major
strategies for patients with leukemia including bone marrow
transplant, radiotherapy, and chemotherapy [18, 19]. How-
ever, the cure rate and side eﬀects are still unsatisﬁed, and
to ﬁnd new agent for leukemia patients is urgent. Numerous
clinical drugs for cancer patients are obtained from natural
products. Although various studies of biological activities
on emodin have been carried out, regarding the molecular
mechanisms of emodin-acted the cell death in vitro and
promotion of immune responses in animal model in vivo
are still undeﬁned. Therefore, we investigated the eﬀects of
emodin on growth inhibition and apoptotic cell death of
murine WEHI-3 leukemia cells in vitro, and modulation of
immune responses in leukemia mice model in vivo.
2.MaterialandMethods
2.1. Reagents and Antibodies. Dimethyl sulfoxide (DMSO),
N-acetylcysteine (NAC), propidium iodide (PI), Triton X-
100, and RNase A were obtained from Sigma-Aldrich Corp.
(St. Louis, MO, USA). The pan-caspase inhibitor (Z-VAD-
FMK), caspase-3 inhibitor (Z-DEVD-FMK), and caspase-
9 inhibitor (Z-LEHD-FMK) were purchased from R&D
Systems (Minneapolis, Menn, USA). All primary antibodies
were obtained from Santa Cruz Biotechnology, Inc. (Santa
Cruz, Calif, USA). The peroxidase-conjugated secondary
antibodies were purchased from Santa Cruz Biotechnology,
Inc. Enhanced chemiluminescence (ECL) kit and Western
blotting reagents were purchased from Pierce Chemical Co.
(Rockford, Ill, USA).
2.2. In Vitro Studies
2.2.1. Murine Leukemia Cell Line. WEHI-3 murine myelo-
monocytic leukemia cell line was purchased from the Food
Industry Research and Development Institute (Hsinchu,
Taiwan). Cells were seeded in 75-cm2 cell culture ﬂasks and
maintained in RPMI 1640 medium supplemented with 10%
fetal bovine serum (FBS), 2mM L-glutamine 100U/mL
penicillin, and 100μg/mL streptomycin at 37◦Cu n d e ra
humidiﬁed 5% CO2 atmosphere.
2.2.2. Cell Growth Inhibition Assay. T h ev i a b l eW E H I - 3c e l l s
were assessed by the MTT assay. About 1 × 104 cells/100μL
per well plated in 96-well plates were treated with emodin
at 0, 25, 50, 100, and 150μMf o r2 4a n d4 8 h .M T T
solution (Sigma-Aldrich Corp., 5mg/mL) was prepared and
a volumeof10μL was individually added toeach well for4-h
incubation [20]. MTT is reduced to form purple formazan
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Figure 1: Emodin aﬀected the percentage of viable cells and DNA
fragmentation in WEHI-3 cells. Cells (1 × 104 cells/well; 96-well
plates) were plated in RPMI 1640 medium + 10% fetal bovine
serum (FBS) with 0, 25, 50, 100, and 150μMo fe m o d i nf o r2 4a n d
48h. The cells were collected by centrifugation and the viable cells
were determined by using the MTT assay (a). Cells were treated
with 0, 50, and 100μM of emodin for 24h, and then DNA was
isolated for DNA gel electrophoresis (b) as described in Section 2.
Columns, mean of three determinations; bars, SD. a, P<. 05 shows
signiﬁcantly diﬀerent when compared with DMSO-treated control;
b, c, and d, P<. 05 indicates signiﬁcantly diﬀerent compared with
25, 50, and 100μM emodin-treated groups, respectively (one-way
ANOVA followed by Bonferroni’s test for multiple comparisons).
product by the mitochondrial dehydrogenases of viable cells.
The MTT-purple formazan productions were dissolved in
DMSO and then were measured by absorbance at 570nm in
an ELISA plate reader as described previously [20].
2.2.3. DNA Laddering Fragmentation. Approximately 2 ×
105 cells/well of WEHI-3 cells were grown in 12-well plates
and treated with 0, 50, 100, and 150μMo fe m o d i nf o r2 4h .
DNA was isolated from emodin-treated and untreated cellsEvidence-Based Complementary and Alternative Medicine 3
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Figure2:Eﬀects ofemodinonapoptosisandDNAdamageinWEHI-3cellsbyusingDAPIstainingandCometassay.Cells(2×10
5 cells/well)
in 12-well plate were incubated with 0, 25, 50, and 100μM emodin for 24h and apoptosis was determined using DAPI staining (a). Data
represent mean ± SDofatleastthree experiments. Cells were treated with 0,50,and100μM emodinfor24h andthenwere harvested forthe
examinationofDNA damageusingthe Comet assay(b) asdescribed in Section 2. Comet tail length wascalculated, quantiﬁed and expressed
in mean ± S.D for at least three replicates. ∗Signiﬁcantly diﬀerent compared with DMSO-treated control, P<. 05, and ∗∗∗signiﬁcantly
diﬀerent from the control sample at P<. 001.
and then were measured in 1.5% agarose gel electrophoresis,
followed to photograph after being stained with ethidium
bromide (Sigma-Aldrich Corp.) under UV illumination as
described previously [21].
2.2.4. DAPI Staining for Apoptosis. Cells (2 × 105 cells/well)
were seeded in 12-well plates and emodin was individually
added tothe cells at ﬁnal concentrations at 0,50, and 100μM
for 24h. Cells were harvested, washed with PBS, and ﬁxed
with 4% paraformaldehyde. The ﬁxed cellswere thenwashed
with PBS and stained with 4,6-diamidino-2-phenylindole
(DAPI, 1μg/mL; Invitrogen) for 30min in the dark. Cells
were then examined and determined under a ﬂuorescent
microscope, photographed and apoptotic cells identiﬁed
[22, 23].4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Emodin aﬀected the levels of ROS, Ca2+ and ΔΨm in WEHI-3 cells. Cells were cultured in 100μM emodin for 0, 1, 3, 6, 12 or
24h.Cells were harvested and resuspended in DCFH-DA fordetermining the changes in ROS (a),in Fluo-3/AM forstainingof Ca2+ (b) and
in DiOC6 for determining ΔΨm (c) as described in Section 2. ∗P<. 05 and ∗∗∗P<. 001 were considered signiﬁcant when compared with
DMSO-treated control.
2.2.5. Comet Assay for DNA Damage. The Comet assay was
followed the procedures of Wang et al. with some modiﬁ-
cations [24]. Cells (2 × 105 cells/well) in 12-well plates were
incubated with 0, 25, 50, and 100μMo fe m o d i nf o r2 4 h .
Cells were harvested for the examination of DNA damage
using the Comet assay. Comets of cells on slides acquired
DNA damage by using the CometScore Freeware analysis
(TriTek Corporation, Sumerduck, VA, USA). Comet tail
length was calculated, quantiﬁed, and expressed in mean ±
S.D. as previously described [23].Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: Emodin stimulated the activities of caspase-3 and -9 of
WEHI-3 cells. Cells were seeded in RPMI 1640 medium + 10% FBS
with pretreatment with NAC, inhibitors of caspase-9 and -3 or a
pan-caspase inhibitor, and then were exposed to 100μMo fe m o d i n
for 24h. Cells were determined the caspase-3, -8, and -9 activity
(a) and percentage of viable cells (b) as described in Section 2.
Each experiment was done with triple sets, and columns, mean of
three determinations; bars, SD. ∗P<. 05 and ∗∗∗P<. 001 were
considered signiﬁcant diﬀerent as compared to the DMSO-treated
control group.
2.2.6. Detection of Reactive Oxygen Species (ROS), Ca2+ Pro-
ductionLevels and MitochondrialMembrane Potential(ΔΨm).
Cells (2 × 105 cells/mL) in RPMI 1640 medium were treated
with 100μM of emodin for 0, 1, 3, 6, 12, or 24h. The cells
were harvested, washed twice with PBS, and then resus-
pendedin500μLof2,7-dichlorodihydroﬂuoresceindiacetate
(10μM) (DCFH-DA) for determining the changes in ROS,
in 500μL of Fluo-3/AM (2.5μg/mL) for staining of Ca2+
and in 500μLo fD i O C 6 (500nmol/L) for determining ΔΨm.
Cells then were individually incubated at 37◦Cf o r3 0 m i n
and were analyzed by ﬂow cytometry (Becton Dickinson
FACSCalibur, San Jose, Calif, USA) and BD CellQuest Pro
software [21, 23, 25].
2.2.7. Determinations for Caspase-3, -8 and -9 Activity. Cells
(1 × 106 cells/mL) in RPMI 1640 medium in 10-cm dishes
were exposed to 100μMo fe m o d i nf o r2 4 ho rp r e t r e a t e d
with a pan-caspase inhibitor (10μM, Z-VAD-FMK) for 3h.
The cells were harvested and lysed in lysis buﬀer (50mM
Tris-HCl (pH 7.4), 1mM EDTA, 10mM EGTA, 10mM digi-
tonin and 2mM DTT). The cell lysates (50μg proteins) were
incubated with caspase-3, -9, and -8 speciﬁc substrates (Ac-
DEVD-pNA, Ac-LEHD-pNA, and Ac-IETD-pNA) (R&D
systems Inc., Minneapolis, MN, USA) for 1h at 37◦C. The
caspases activities were determined by measuring the release
of pNA at OD405 as previously described [26, 27]. Cells
were also pretreated with the caspase-9 inhibitor (10μM,
Z-IETD-FMK), caspase-3 inhibitor (10μM, Z-DEVD-FMK)
(R&D Systems) and NAC, and then were treated with
100μM emodin for 24-h exposure. Cells were harvest for
determination of viability as previously described [28, 29].
2.2.8. Western Blotting forExamining the Apoptosis-Associated
Protein Levels. Cells (2 × 105 cells/mL) in RPMI 1640
medium were treated with 100μM of emodin for 0, 6, 12,
and 24h, isolated cells from each treatment were lysed and
the protein levels were determined as described previously
[15, 25] for determining apoptosis-associated proteins levels
such as caspase-3, -7 and -9, PARP, cytochrome c,A p a f -
1, AIF, Endo G, GADD153, GRP78, ATF-6α, Bcl-2, Bcl-xL,
Bax and Bad. All samples were separated by sodium dodecyl
sulfate polyacrylamide (SDS-PAGE) gel electrophoresis as
described previously[15, 25]. Quantiﬁcation ofband density
was determined using NIH Image J software.
2.3. In Vivo Studies
2.3.1. BALB/c Mice. Fifty male BALB/c mice, each was ap-
proximately 22–28g in body weight at 8 weeks of age were
purchased from the Laboratory Animal Center, College
of Medicine, National Taiwan University (Taipei, Taiwan).
These animals were maintained at 25◦C on a 12-h light/dark
cycle in the animal center of the China Medical University
followed the animal guideline as previously described [30,
31].
2.3.2. Emodin Treatment. F i f t ym i c ew e r er a n d o m l yd i v i d e d
into 5 groups (10 animals per group). Group I was control
(normal animal) and Group II was only treated olive oil.
Group III was intraperitoneally (i.p.) injected with WEHI-3
cells(1×105 cells)and theoliveoiltreatmentonlyasnegative
control. Group IV was i.p. injected with WEHI-3 cells (1 ×
105 cells) and orally treated with emodin (5mg/kg) in olive
oil.GroupVwasi.p.injectedwithWEHI-3cells(1×105 cells)
and oral treatment with emodin (10mg/kg) in olive oil
[8, 32]. Emodin (5 and 10 mg/kg) was administered by oral
gauge in 100μL of olive oil. Animals were inoculated with
WEHI-3 cells for 2 weeks of incubation, and subsequently
leukemia mice were administrated daily for 2 weeks before
being weighed and sacriﬁced.
2.3.3. Blood Collection and Immunoﬂuorescence Staining.
After emodin treatment for 2 weeks, one mL of blood was
collected from each mouse of examined groups. The indi-
vidual samples were added 1 × Pharm Lyse lysing buﬀer
(BD Biosciences, San Jose, CA, USA) for lysing of the red6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Emodin aﬀected the apoptosis-associated protein levels in WEHI-3 cells. Cells were treated with emodin at 100μM for 0, 6, 12,
and 24h, and then the total proteins were prepared and determined as described in Section 2. The levels of associated proteins expressions
((a):caspase-3,-7,and-9 andPARP;(b):cytochrome c, Apaf-1, AIF andEndo G; (c): GADD153, GRP78, ATF-6α andcaspase-12;(d):Bcl-2,
Bcl-xL, Bax, and Bad) were estimated by Western blotting as described in Materials and Methods.
blood cells and then centrifuged at 1000 × ga t4 ◦Cf o r
15min. Isolated white blood cells were stained with anti-
CD3-ﬂuorescein isothiocyanate (FITC), -CD11b-FITC, -
CD19-phycoerythrin (PE), and -Mac-3-PE antibodies (BD
Pharmingen, San Diego, CA, USA) for measuring the cell
surface markers of T cell (CD3), B cell (CD19), monocytes,
and macrophages (CD11b and Mac-3, resp.) and then were
determined the cell marker levels by ﬂow cytometry as
previously described [30, 33].
2.3.4. Phagocytic Activity of Monocytes and Macrophages.
Leukocytes from the mice were collected for determining
the phagocytosis by using a PHAGOTEST kit (Glycotope
Biotechnology GmbH/Orpegen Pharma, Heidelberg, Ger-
many) as previously described [30, 31]. Cells were isolated
from peripheral blood mononuclear cells (PBMC), and
peritoneal cavity of control and emodin-treated animals.
Isolated cells were individually incubated with opsonised
FITC-labeled E. coli (20μL) for 1h at 37◦C according to
the manufacturer’s instruction. After incubation, an ice-cold
quenching solution (100μL )w a sa d d e dt os t o pt h er e a c t i o n
then and DNA content of the monocytes/macrophages for
cell cycle analysis. Cells were prepared then were analyzed
by ﬂow cytometery. Fluorescence data were collected on
10,000 cells by ﬂow cytometry and analyzed using the BD
CELLQUEST Pro software [30, 31].Evidence-Based Complementary and Alternative Medicine 7
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Figure 6: The proposed mechanisms of emodin-induced apoptosis in WEHI-3 cells. The ﬂow chart shows that emodin induced apoptosis
through the ER stress, mitochondria-, and caspase-3-dependent signalingpathways in murine leukemia WEHI-3 cells in vitro.
2.4. Statistical Analyses. Data were expressed as mean ± SD
and diﬀerences between control and emodin-treated groups
were analyzed by one-way ANOVA followed by Bonferroni’s
test formultiple comparisons or Dunnett’stest. ∗P<. 05and
∗∗∗P<. 001 were considered signiﬁcant.
3.Results
3.1. Emodin Induced Cytotoxic Eﬀects and DNA Fragmenta-
tion in WEHI-3 Cells. The doses of emodin (50 to 150μM)
are required to induce cell death in WEHI-3 cells for 24-
h treatment and the percentage of viable cells decrease was
41–63% (Figure 1(a)). However, emodin (25–150μM) for
48-h treatment decrease viable cells and the results show
19–82% (Figure 1(a)). Herein, emodin in the concentration
as low as 25μM initiated cell death of WEHI-3 cells and
the IC50 is 100μM( F i g u r e1(a)). DNA gel electrophoresis
assay indicated that 100–150μM of emodin-induced DNA
fragmentation in WEHI-3 cells after exposure for 24h
(Figure 1(b)).
3.2. Emodin Induced Apoptosis and DNA Damage in WEHI-
3 Cells. To investigate the mechanism of emodin-induced
leukemic cell death, the eﬀect of emodin on DNA damage
was evaluated. The eﬀects of emodin on DNA integrity were
further analyzed using the DAPI staining and Comet assay.
Emodin-induced chromatin condensation (an apoptotic
characteristic) in a dose-dependent response (Figure 2(a)).
Also, emodin triggered DNA damage after 24-h treatment
and quantiﬁcation of the number of leukemic WEHI-3 cells
displaying a Comet tail strongly increased after emodin
treatment (Figure 2(b)).
3.3. Emodin Altered the Levels of ROS, Ca2+ and ΔΨm in
WEHI-3 Cells. Cellstreatedwith100μM emodinweredeter-
minedbyﬂowcytometricassaysandresultsareshowninFig-
ures 3(a), 3(b),a n d3(c), which indicated that emodin pro-
moted the levelsofROS(Figure3(a))a n dC a 2+(Figure3(b)),
but decreased the level of ΔΨm (Figure 3(c)). To investigate
emodin-inducedcelldeathisthroughthedisruptionofmito-
chondrial respiratory chain, leading to ROS accumulation
andcellulardamage.Anincrease inintracellularﬂuorescence
after DCFH-DA loading showed the reversal of ROS accu-
mulation (Figure 3(a)). In order to elucidate the mechanism
of emodin-induced mitochondria-dependent apoptotic cell
death,theeﬀectsofemodinonthelevelsofintracellularCa2+
and ΔΨm were analyzed. These data indicated that emodin-
induced apoptosis is possibly mediated through alteration
of mitochondrial permeability transition in WEHI-3 cells in
vitro.
3.4. Emodin Aﬀected Activities of Caspase-3 and -9 of WEHI-
3 Cells. In order to evaluate the roles of caspase-mediated
pathways in emodin-induced apoptotic death of WEHI-3
cells, cells were pretreated with a pan-caspase inhibitor (Z-
VAD-FMK), and then exposed to emodin. We found that
emodin promoted the activities of caspase-3 and -9, but it
did not aﬀe c tt h a to fc a s p a s e - 8( F i g u r e4(a)). Pretreatment
with Z-VAD-FMK could decrease emodin-stimulated the
activities of caspase-3 and -9 in WEHI-3 cells (Figure 4(a)).
Furthermore, cells were individually preincubated with8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Emodin aﬀected the weights of the leukemia mice which were treated with without or with emodin 2 weeks. BALB/c mice were
intraperitoneally injected with WEHI-3 cells (1 × 105 cells/100μL) in PBS for 2 weeks and/or treated with emodin once daily by oral
administration for 14 days. Blood was collected and animals were sacriﬁced for examinations of weights of body (a) spleen (b) and liver
(c) tissues, and then were individually weighed. Each point is the mean ± SD and similar results were observed in at least three independent
experiments (n = 10) followed by one-way ANOVA followed by Dunnett’s test.
an antioxidant scavenger (NAC), caspase-9 inhibitor (Z-
IETD-FMK), and caspase-3 inhibitor (Z-DEVD-FMK),
which led to increase emodin-reduced the percentage of
viable WEHI-3 cells compared to the emodin-treated cells
only (Figure 4(b)). These data suggest that emodin triggered
apoptosis of WEHI-3 cells through the ROS and caspase-
dependent pathways.
3.5. Emodin Altered the Apoptosis-Associated Protein Levels in
WEHI-3 Cells. Cells were exposure to 100μMo fe m o d i nf o r
0, 6, 12, and 24h and then the total protein were prepared
and determined by Western blotting analysis. These results
are presented in Figure 5 ((a): caspase-3, -7 and -9, PARP;
(b): cytochrome c, Apaf-1, AIF, Endo G; (c): GADD153,
GRP78, ATF-6α, caspase-12; (d): Bcl-2, Bcl-xL, Bax, and
Bad), which indicated that the levels of caspase-3, -7 and
-9, PARP (Figure 5(a)) ,c y t o c h r o m ec ,A p a f - 1 ,A I F ,E n d oG
(Figure 5(b)), GADD153, GRP78, ATF-6α,c a s p a s e - 1 2
(Figure 5(c)), Bax, and Bad (Figure 5(d)) were increased,
while the levels of Bcl-2 and Bcl-xL (Figure 5(d))w e r e
decreased and these eﬀects may lead to cell apoptosis.
Overall, the proposed possible signal pathways for emodin-
induced apoptosis are shown in Figure 6.
3.6. Emodin Aﬀected the Weight of BALB/c Mice after Injec-
tion with WEHI-3 Cells and/or Exposure to Emodin for 2
Weeks. The BALB/c mice after injection with WEHI-3 cells
were treated with or without emodin (5 and 10mg/kg).
Results indicate that emodin increased the body weight of
mice (Figure 7(a)) but decreased the weights of spleen
(Figure 7(b))a n dl i v e r( F i g u r e7(c))w h e nc o m p a r e dw i t h
t h el e u k e m i am i c eg r o u p .
3.7. Emodin Aﬀected the Cell Markers of White Blood Cells
from Leukemia BALB/c Mice. The leukemia mice were
orally treated without (control) or with emodin (5 andEvidence-Based Complementary and Alternative Medicine 9
WEHI-3/
emodin
10mg/kg
WEHI-3/
emodin
5mg/kg
WEHI-3 Olive oil Control
0
10
20
30
40
50
C
D
3
(
%
)
N.S.
N.S.
(a)
WEHI-3/
emodin
10mg/kg
WEHI-3/
emodin
5mg/kg
WEHI-3 Olive oil Control
0
10
20
30
40
50
C
D
1
9
(
%
)
∗
(b)
WEHI-3/
emodin
10mg/kg
WEHI-3/
emodin
5mg/kg
WEHI-3 Olive oil Control
0
10
20
30
40
50
C
D
1
1
b
(
%
)
∗
(c)
WEHI-3/
emodin
10mg/kg
WEHI-3/
emodin
5mg/kg
WEHI-3 Olive oil Control
0
5
10
15
20
M
a
c
-
3
(
%
)
∗
∗
(d)
Figure 8: Emodin aﬀected the cell markers of white blood cells from leukemia BALB/c mice. The leukemia mice were orally treated without
and with emodin (5 and 10mg/kg) in olive oil for 14 days. Blood was collected from individual animals and was analyzed for surface
cell markers by ﬂow cytometry as described in Section 2.E a c hp o i n ti st h em e a n± SD and similar results were observed in at least three
independent samples (n = 10) followed by one-way ANOVA followed by Dunnett’s test. N.S. = Not Signiﬁcant (P>. 05).
10mg/kg) for 14 days. Blood was collected individually from
animals of each group and was analyzed for cell markers
by ﬂow cytometry. The results are shown in Figures 8(a),
8(b), 8(c),a n d8(d).E m o d i nd i dn o ta ﬀect the level of CD3
surface marker (Figure 8(a)); however, emodin increased
the levels of CD19 (Figure 8(b)) and CD11b (Figure 8(c))
in emodin-treated groups and it also decreased the level of
Mac-3 marker after emodin at 5 and 10mg/kg treatment
(Figure 8(d))i nc o m p a r i s o nt ol e u k e m i am i c eg r o u p .
3.8. Emodin Aﬀected on Phagocytosis by Monocytes and Ma-
crophages from BALB/c Mice. Animals were injected with
WEHI-3 cells for 2 weeks and then treated without or with
emodin for 2 weeks. Leukocytes were collected from PBMC
and the peritoneal cavity and were analyzed for phagocytosis
of monocytes and macrophages by ﬂow cytometry. Results
shown in Figures 9(a) and 9(b) indicate that emodin pro-
moted the phagocytosis from PBMC and peritoneal cavity of
leukemia mice.
4.Discussion
The major diﬀerences between leukemic cells and tumors
are that leukemic cells capable of circulating and having
access to various organs through interaction with activated
vascular cells [34]. However, the subsets of leukemic cells
may also adhere to vascular cells forestablishing perivascular
inﬁltrates then may be endowed with a unique mechanism
of resistance to chemotherapy. It is well documented that
circulating and vascular-adherent leukemic cells require
cytoskeletal stability for maintaining mitochondrial and cel-
lular function to avoid cell death [35]. In this study, we show
that various doses of emodin selectively induced apoptosis
of murine WEHI-3 leukemic cells by caspase-dependent
response as well as ROS-mediated signal pathways for
l e a d i n gt oc e l ld e a t h .M o r e o v e r ,w ea l s of o u n dt h a te m o d i n -
triggered apoptotic death is involved in the unfolded protein
response (endoplasmic reticulum stress) in WEHI-3 cells.
The molecular mechanisms of emodin-caused cell death are10 Evidence-Based Complementary and Alternative Medicine
WEHI-3/
emodin
10mg/kg
WEHI-3/
emodin
5mg/kg
WEHI-3 Olive oil Control
0
10
20
30
40
50
P
h
a
g
o
c
y
t
o
t
i
c
a
c
t
i
v
i
t
y
(
%
)
∗
(a)
WEHI-3/
emodin
10mg/kg
WEHI-3/
emodin
5mg/kg
WEHI-3 Olive oil Control
0
5
10
15
20
25
30
P
h
a
g
o
c
y
t
o
t
i
c
a
c
t
i
v
i
t
y
(
%
)
∗
∗∗∗
(b)
Figure 9: Emodin aﬀected on phagocytosis by monocytes and macrophages from leukemia BALB/c mice. Mice were injected with WEHI-3
cells (1 × 10
5 cells/100μL) in PBS for 2 weeks and treated without or with emodin for 2 weeks. Leukocytes were collected from PBMC (a)
and peritoneal cavity (b) from animals and were analyzed for phagocytosis by ﬂow cytometry as described in Section 2.E a c hp o i n ti st h e
mean ± SD and similar results were observed in at least three independent samples (n = 10), and ∗P<. 05 and ∗∗∗P<. 001 (n = 10) were
shown signiﬁcant followed by one-way ANOVA followed by Dunnett’s test.
complex and most likely mediated through recruitment of
caspase-dependent and -independent pathways.
In leukemia cells, various concentrations of emodin have
been shown to result in caspase activations and apoptotic
cell death [9, 36]. Emodin also induced G2/M phase arrest
and subsequent cell death in leukemia cells [9]. However,
ourdatashowed that emodin impaired leukemiccell survival
by caspases activation and in part through ROS production,
Ca2+ release and the disruption of ΔΨm and releases of some
proapoptotic factors including cytochrome c,A I Fa n dE n d o
G. Mitochondrial dysfunction might result in the release of
cytochrome c,A I Fa n dE n d oGi ne m o d i n - t r e a t e dW E H I - 3
cells as can be seen in Figure 5.
Mitochondrial membrane potential disruption and
G2/M arrest havepreviously beendescribed inleukemiacells
upontreatmentwith emodinoraloe-emodin andrhein from
rhubarb (Da-huang) [8, 9, 37, 38]. In the present study, our
data suggest that emodin induced leukemic cell death by an
apoptotic pathway that is distinct from conventional other
compounds agents. We also examined whether emodin-
induced mitochondrial damage promoted the release of
cytochrmoe c,A I Fa n dE n d oG( F i g u r e5(b)). AIF and
Endo G that are ubiquitously expressed ﬂavoproteins, which
might play a critical role in caspase-independent apoptosis
[39, 40]. It was reported that AIF is similar to cytochrome
c normally localized to the mitochondrial intermembrane
space and released in response to apoptotic stimuli [41].
Our results also showed that emodin promoted the level
of Bax, and decreased the level of Bcl-2 (Figure 5(c)), and
it is well documented that the ratio of Bax/Bcl-2 involved
the dysfunction of mitochondria, resulting in cell apoptosis
[42]. Bcl-2, an upstream eﬀector molecule in the apoptotic
pathway, has been recognized to be a potent suppressor of
apoptosis [43], and most cancers generally overexpress Bcl-
2[ 44, 45]. In the present study, we observed that emodin
signiﬁcantly downregulated Bcl-2 protein and up-regulated
the level of Bax protein in WEHI-3 cells (Figure 5(d)),
suggesting that the involvement of an intrinsic apoptotic
pathwayismediatedinemodin-induced apoptosisinWEHI-
3 cells.
Our results also showed that emodin promoted ROS
and Ca2+ production in WEHI-3 cells (Figure 3). We also
used DAPI staining and Comet assay to show that emodin
induced DNA damage in WEHI-3 cells (Figure 4). As the
increased ROS accumulation and DNA damage have been
identiﬁed as mediators or initiators of apoptosis in certain
condition [46]. These data indicated that emodin-induced
cell death in WEHI-3 cells is mediated via loss of ΔΨm,
leading to intracellular ROS and DNA damage then followed
by caspase-3 activation and the releases of AIF and Endo G
for causing apoptosis. We further showed that these events
lead to cell death via caspase-dependent or -independent
mitochondrial apoptosis with DNA fragmentation. Taken
together, these data indicate that emodin might induce cell
death in part through a caspase-dependent as well as in part
through a caspase-independent (mitochondria-dependent
led to AIF and Endo G and ER stress) apoptotic pathway
by accumulation of ROS as a result of the disruption of the
mitochondria in WEHI-3 cells as shown in Figure 6.
Emodin induced apoptosis in human promyeloleukemic
HL-60cellsaccompaniedbyactivationofcaspasecascadebut
independent ROS production [9]. However, other reports
also showed that emodin induced apoptosis in human lung
adenocarcinoma cells through a ROS-dependent mitochon-
drial signaling pathway [11]. Our previous studies also
showed that emodin induced apoptosis in SCC-4 cells
through the production of ROS and mitochondria-depend-
ent pathways [15]. Currently, we showed that emodin
inducedapoptosisinmurineleukemiaWEHI-3cellsthrough
ROS production, caspase-3 and mitochondria-dependentEvidence-Based Complementary and Alternative Medicine 11
pathways. Therefore, it is raising the possibility that emodin
may have some chemotherapeutic chance for human leu-
kemia. However, the eﬀects of emodin on leukemia in vivo
provided no clear information.
Other reports [47] and our previous studies [48, 49]a l s o
showed the in vivo model through the mice intraperitoneally
injected with WEHI-3 cells is well established. This mice
model has been demonstrated as an ideal system for the
study of potential therapeutic drugs (ATRA, aclacinomycin
A, IL-6, G-CSF, and vitamin D3) which could induce in
vitro diﬀerentiation of WEHI-3 cells in monocytic and
granulocytic lineages [50–52]. Therefore, the purpose of this
study was to examine the eﬀects of emodin on WEHI-3
cells in BALB/c mice in vivo. Herein, our results showed
that emodin inhibited spleen leukemia tumor growth in
a WEHI-3 leukemia murine model. We observed that the
size of the spleens decreased the emodin-treated leukemia
groups.Theseobservationswerealsoseeninlivertissues,and
there was a signiﬁcant diﬀerence between the control and
emodin-treated groups (Figure 7). Emodin also promoted
the phagocytosis by monocytes and macrophages in PBMC
and peritoneal cavity of WEHI-3 leukemia mice in vivo
(Figure 9).
In summary, emodin provokes apoptosis in mice leuke-
mia WEHI-3 cellsin vitro and tendstoinhibit leukemiamice
through stimulating phagocytosis in vivo. Our study is the
ﬁrst report and the in vitro the linkages of apoptotic cell
death and the in vivo phagocytic activity of macrophages or
monocytes were indeed needed for further investigation.
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